AMICUS THERAPEUTICS, INC. - Common Stock (FOLD)
CUSIP: 03152W109
Q4 2017 13F Holders as of 31 Dec 2017
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 312,579,912
- Total 13F shares
- 205,784,956
- Share change
- +4,917,854
- Total reported value
- $2,961,554,572
- Put/Call ratio
- 92%
- Price per share
- $14.39
- Number of holders
- 181
- Value change
- +$69,146,321
- Number of buys
- 97
- Number of sells
- 80
Quarterly Holders Quick Answers
What is CUSIP 03152W109?
CUSIP 03152W109 identifies FOLD - AMICUS THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03152W109:
Top shareholders of FOLD - AMICUS THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
6.2%
|
19,315,817
|
$291,283,000 | — | 30 Sep 2017 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
5.7%
|
17,888,597
|
$269,760,000 | — | 30 Sep 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.3%
|
13,369,236
|
$201,608,000 | — | 30 Sep 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.2%
|
13,280,868
|
$200,275,000 | — | 30 Sep 2017 | |
| Redmile Group, LLC |
13F
|
Company |
3.5%
|
11,012,561
|
$166,069,000 | — | 30 Sep 2017 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
3.1%
|
9,772,025
|
$147,362,000 | — | 30 Sep 2017 | |
| STATE STREET CORP |
13F
|
Company |
2.6%
|
8,151,091
|
$122,917,000 | — | 30 Sep 2017 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.6%
|
8,092,031
|
$122,028,000 | — | 30 Sep 2017 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.4%
|
7,434,314
|
$112,109,000 | — | 30 Sep 2017 | |
| Palo Alto Investors LP |
13F
|
Company |
2.4%
|
7,420,288
|
$111,898,000 | — | 30 Sep 2017 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
2.1%
|
6,437,122
|
$97,072,000 | — | 30 Sep 2017 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.9%
|
6,061,734
|
$91,411,000 | — | 30 Sep 2017 | |
| MORGAN STANLEY |
13F
|
Company |
1.9%
|
5,992,250
|
$90,362,000 | — | 30 Sep 2017 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.6%
|
5,081,055
|
$76,622,000 | — | 30 Sep 2017 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.4%
|
4,505,500
|
$67,943,000 | — | 30 Sep 2017 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.1%
|
3,312,400
|
$49,951,000 | — | 30 Sep 2017 | |
| Tourbillon Capital Partners, L.P. |
13F
|
Company |
0.97%
|
3,038,300
|
$45,818,000 | — | 30 Sep 2017 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.86%
|
2,698,502
|
$40,450,000 | — | 30 Sep 2017 | |
| FRAZIER MANAGEMENT LLC |
13F
|
Company |
0.83%
|
2,600,014
|
$39,208,000 | — | 30 Sep 2017 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.8%
|
2,493,169
|
$37,597,000 | — | 30 Sep 2017 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.77%
|
2,412,870
|
$36,386,000 | — | 30 Sep 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.74%
|
2,316,785
|
$34,935,000 | — | 30 Sep 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.63%
|
1,976,859
|
$29,812,000 | — | 30 Sep 2017 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.6%
|
1,876,558
|
$28,298,000 | — | 30 Sep 2017 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.56%
|
1,739,446
|
$26,231,000 | — | 30 Sep 2017 | |
| PointState Capital LP |
13F
|
Company |
0.53%
|
1,666,900
|
$25,137,000 | — | 30 Sep 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.47%
|
1,473,089
|
$22,214,000 | — | 30 Sep 2017 | |
| NORGES BANK |
13F
|
Company |
0.4%
|
1,247,933
|
$18,819,000 | — | 30 Sep 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.4%
|
1,262,000
|
$18,551,000 | — | 30 Sep 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.38%
|
1,177,850
|
$17,762,000 | — | 30 Sep 2017 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.29%
|
913,742
|
$13,779,000 | — | 30 Sep 2017 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.29%
|
910,000
|
$13,723,000 | — | 30 Sep 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.27%
|
858,183
|
$12,941,000 | — | 30 Sep 2017 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.24%
|
754,759
|
$11,381,000 | — | 30 Sep 2017 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.23%
|
732,328
|
$11,044,000 | — | 30 Sep 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.23%
|
731,875
|
$11,037,000 | — | 30 Sep 2017 | |
| Artal Group S.A. |
13F
|
Company |
0.22%
|
700,000
|
$10,556,000 | — | 30 Sep 2017 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.22%
|
676,117
|
$10,196,000 | — | 30 Sep 2017 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.21%
|
658,078
|
$9,924,000 | — | 30 Sep 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.18%
|
550,188
|
$8,297,000 | — | 30 Sep 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.17%
|
529,913
|
$7,991,000 | — | 30 Sep 2017 | |
| AXA S.A. |
13F
|
Company |
0.17%
|
518,172
|
$7,814,000 | — | 30 Sep 2017 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.16%
|
488,576
|
$7,368,000 | — | 30 Sep 2017 | |
| S.c.a. Candriam |
13F
|
Individual |
0.15%
|
482,400
|
$7,275,000 | — | 30 Sep 2017 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.15%
|
467,900
|
$7,056,000 | — | 30 Sep 2017 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.14%
|
426,589
|
$6,433,000 | — | 30 Sep 2017 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.13%
|
420,000
|
$6,334,000 | — | 30 Sep 2017 | |
| CADIAN CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.13%
|
400,000
|
$6,032,000 | — | 30 Sep 2017 | |
| ARDSLEY ADVISORY PARTNERS LP |
13F
|
Company |
0.12%
|
365,000
|
$5,504,000 | — | 30 Sep 2017 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
362,440
|
$5,466,000 | — | 30 Sep 2017 |
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q4 2017
As of 31 Dec 2017,
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) was held by
181 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
205,784,956 shares.
The largest 10 holders included
FMR LLC, PERCEPTIVE ADVISORS LLC, BlackRock Inc., Vanguard Group Inc, Redmile Group, LLC, JENNISON ASSOCIATES LLC, PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, STATE STREET CORP, and venBio Select Advisor LLC.
This page lists
181
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
183
Q4 2017 holders
181
Holder diff
-2
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.